Yahoo
Argus

Argus

May 27, 2026

TMDX: Raising target price to $67.00

Symbols

TMDX

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$67.20

Price Target

Summary

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ fai

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: